Advantages of one- and two-photon light in inverse scattering.

We study an inverse scattering problem in which the far-field spectral cross correlation functions of scattered fields are used to determine the unknown dielectric susceptibility of the scattering object. One-photon states for the incident field can resolve (at 100 visibility) twice as many Fourier components of the susceptibility compared with the (naïve) Rayleigh estimate, provided that the measurement is performed in the back-scattering regime. Coherent states are not capable of reaching this optimal resolution (or do so with negligible visibility).

Friction forces on atoms after acceleration.

The aim of this paper is to revisit the calculation of atom-surface quantum friction in the quantum field theory formulation put forward by Barton (2010 New J. Phys. 12 113045).

[Evaluation of a long-term sensomotor deficit after neonatal rat brain ischemia/hypoxia].

The application of magnetic resonance imaging method showed that ischemia/hypoxia of the brain of neonatal rats made by the protocol suggested by Levine-Rice induces one-sided lesions in the areas of cerebral cortex, striatum and hippocampus. Unilateral ischemic injury leads to a long-term sensorimotor and behavioral distortions within 90-115 days after the operation which has been tested in animals by the battery of tests including Cylinder, Beam-walking, Staircase and Limb-placing test. Chosen battery of tests in combination with magnetic resonance imaging allows to reliably estimate the long-term sensorimotor recovery in adult animals suffered an injury in neonatal age.

[Adaptol--verges of possible].

The analysis of the available in the modern literature researches allows us to consider Adaptol (active substance mebicarum) as drug with tranquilizing, nootropic and antioxidant activity that improves the adaptive capabilities of the body and certain organs and systems. However, described in some studies antianginal and antihyperlipidemic effect of the drug requires clarification of mechanisms of its occurrence: independent or by reducing the impact of stress influence.

[Therapeutic efficacy of mildronate in pulmonary diseases].

Immuno-corrective action of the medication has been proved by analyzing Mildronate administration in 64 patients with bronchial asthma and secondary immunodeficiency. Stimulation of sell component and inhibition of humoral component of the immunity system, improvement of central hemodynamics and normalization of the hemopoiesis system to some extent have been observed in the patients. The patients with chronic catarrhal obstructive bronchitis in acute stage and patients with infection-allergic bronchial asthma showed decrease in bronchial obstruction under the treatment with the medication.